Up a level |
Page, Karen, Martinson, Luke J, Fernandez-Garcia, Daniel, Hills, Allison, Gleason, Kelly LT, Gray, Molly C, Rushton, Amelia J, Nteliopoulos, Georgios, Hastings, Robert K, Goddard, Kate et al (show 10 more authors)
(2021)
Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease.
JCO PRECISION ONCOLOGY, 5 (5).
pp. 1768-1776.
Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert et al (show 1 more authors)
(2019)
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
BREAST CANCER RESEARCH AND TREATMENT, 175 (1).
pp. 149-163.
Coombes, R Charles, Howell, Sacha, Lord, Simon R, Kenny, Laura, Mansi, Janine, Mitri, Zahi, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Chap, Linnea I, Richards, Paul, Gradishar, William et al (show 13 more authors)
(2023)
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
NATURE COMMUNICATIONS, 14 (1).
4444-.
Ruenraroengsak, Pakatip, Kiryushko, Darya, Theodorou, Ioannis G, Klosowski, Michal M, Taylor, Erik R, Niriella, Thisa, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Yague, Ernesto, Ryan, Mary P, Coombes, R Charles et al (show 2 more authors)
(2019)
Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells.
NANOSCALE, 11 (27).
pp. 12858-12870.
Palmieri, Carlo ORCID: 0000-0001-9496-2718, Szydlo, Richard, Miller, Marie, Barker, Laura, Patel, Neva H, Sasano, Hironobu, Barwick, Tara, Tam, Henry, Hadjiminas, Dimitri, Lee, Jasmin et al (show 4 more authors)
(2017)
IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.
BREAST CANCER RESEARCH AND TREATMENT, 166 (2).
pp. 527-539.
Palmieri, Carlo ORCID: 0000-0001-9496-2718, Stein, Rob C, Liu, Xinxue, Hudson, Emma, Nicholas, Hanna, Sasano, Hironobu, Guestini, Fouzia, Holcombe, Chris, Barrett, Sophie, Kenny, Laura et al (show 5 more authors)
(2017)
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
BREAST CANCER RESEARCH AND TREATMENT, 165 (2).
pp. 343-353.